OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
Titel:
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
Auteur:
Robson, Mark E. Im, Seock-Ah Senkus, Elzbieta Xu, Binghe Domchek, Susan M. Masuda, Norikazu Delaloge, Suzette Tung, Nadine Armstrong, Anne Dymond, Mike Fielding, Anitra Allen, Allison Conte, Pierfranco